{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T03:37:41Z","timestamp":1782704261938,"version":"3.54.5"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Surgical-site infections (SSIs) are common in liver transplant recipients. The optimal SSI antimicrobial prophylaxis agent and duration are not established. We aimed to explore risk factors for SSIs after transplant, with a particular interest in the impact of perioperative antibiotic regimen on the development of SSIs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>Retrospective study of adults undergoing liver transplant across 3 transplant programs between January 1, 2020, and June 01, 2021.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>Of 557 patients included in the study, 32 (5.7%) were infected or colonized with a multidrug-resistant organism (MDRO) within 1 y before liver transplant. Narrow-spectrum SSI prophylaxis with ceftriaxone or cefazolin alone was administered in 488 of 577 patients (87.6%); the remaining 69 patients (12.4%) received broad-spectrum prophylaxis with vancomycin and aztreonam (n\u2009=\u200940), piperacillin\u2013tazobactam (n\u2009=\u200911), carbapenems (n\u2009=\u20098), ceftriaxone and another antibiotic (n\u2009=\u20097), and others. Patients with pretransplant MDRO were more likely to receive broad-spectrum coverage than those without pretransplant MDROs (28.1% versus 11.4%, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2009=\u20090.005). SSIs were identified in 40 patients (7.2%); 25 (62.5%) were organ\u2013space infections, 3 (7.5%) were deep incisional infections, and 12 (30.0%) were superficial incisional infections. The median time from liver transplant to SSIs was 14 d (interquartile range, 10\u201320.2). MDROs were identified in 12 SSIs (30%). Multivariable analysis revealed no significant association between antimicrobial spectrum and risk of SSIs (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2009=\u20090.5), whereas surgical leak (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001) and reoperation (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2009=\u20090.017) were independently associated with increased risk of SSIs. SSIs were not significantly associated with composite risk of death or liver allograft failure.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>The spectrum of antimicrobial prophylaxis did not impact the development of SSIs in liver transplant recipients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000004810","type":"journal-article","created":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T05:02:01Z","timestamp":1701666121000},"page":"1179-1188","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Risk Factors for Surgical-site Infections After Liver Transplant: Does Perioperative Antibiotic Regimen Matter?"],"prefix":"10.1097","volume":"108","author":[{"given":"Stacey C.","family":"Rolak","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary A.","family":"Yetmar","sequence":"additional","affiliation":[{"name":"Division of Public Health, Infectious Diseases, and Occupational Medicine, Department of Internal Medicine, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian D.","family":"Lahr","sequence":"additional","affiliation":[{"name":"Division of Public Health, Infectious Diseases, and Occupational Medicine, Department of Internal Medicine, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Beam","sequence":"additional","affiliation":[{"name":"Division of Public Health, Infectious Diseases, and Occupational Medicine, Department of Internal Medicine, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samrah","family":"Razi","sequence":"additional","affiliation":[{"name":"Division of Public Health, Infectious Diseases, and Occupational Medicine, Department of Internal Medicine, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kymberly","family":"Watt","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Yang","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic, Jacksonville, FL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bashar A.","family":"Aqel","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic, Phoenix, AZ."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Mahmood","sequence":"additional","affiliation":[{"name":"Division of Public Health, Infectious Diseases, and Occupational Medicine, Department of Internal Medicine, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,12,4]]},"reference":[{"key":"R1-20250604","doi-asserted-by":"crossref","first-page":"e13589","DOI":"10.1111\/ctr.13589","article-title":"Surgical site infections: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.","volume":"33","author":"Abbo","year":"2019","journal-title":"Clin Transplant"},{"key":"R2-20250604","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2146\/ajhp120568","article-title":"Clinical practice guidelines for antimicrobial prophylaxis in surgery.","volume":"70","author":"Bratzler","year":"2013","journal-title":"Am J Health Syst Pharm"},{"key":"R3-20250604","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cmi.2022.12.012","article-title":"ESCMID\/EUCIC clinical practice guidelines on perioperative antibiotic prophylaxis in patients colonized by multidrug-resistant Gram-negative bacteria before surgery.","volume":"29","author":"Righi","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"R5-20250604","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners.","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"R6-20250604","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"R7-20250604","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"R8-20250604","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1017\/ice.2018.164","article-title":"Perioperative antimicrobial prophylaxis and prevention of hepatobiliary surgical site infections.","volume":"39","author":"Stack","year":"2018","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R9-20250604","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/lt.21435","article-title":"Effect of antibiotic prophylaxis on the risk of surgical site infection in orthotopic liver transplant.","volume":"14","author":"Asensio","year":"2008","journal-title":"Liver Transpl"},{"key":"R10-20250604","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1097\/TP.0b013e3181735407","article-title":"Surgical site infection in liver transplant recipients: impact of the type of perioperative prophylaxis.","volume":"85","author":"Garcia Prado","year":"2008","journal-title":"Transplantation"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1097\/TP.0000000000001356","article-title":"Surgical site infections after liver transplantation: emergence of multidrug-resistant bacteria and implications for prophylaxis and treatment strategies.","volume":"100","author":"Viehman","year":"2016","journal-title":"Transplantation"},{"key":"R12-20250604","first-page":"CD013209","article-title":"Perioperative antibiotics for preventing post-surgical site infections in solid organ transplant recipients.","volume":"8","author":"Chan","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"R13-20250604","doi-asserted-by":"crossref","first-page":"115220","DOI":"10.1016\/j.diagmicrobio.2020.115220","article-title":"Surgical site infection after liver transplantation in the era of multidrug-resistant bacteria: what new risks should be considered?","volume":"99","author":"Freire","year":"2021","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R14-20250604","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/TP.0000000000003231","article-title":"Risk factors and impact of perioperative prophylaxis on the risk of extended-spectrum beta-lactamase-producing Enterobacteriaceae-related infection among carriers following liver transplantation.","volume":"105","author":"Logre","year":"2021","journal-title":"Transplantation"},{"key":"R15-20250604","doi-asserted-by":"crossref","first-page":"e13907","DOI":"10.1111\/tid.13907","article-title":"Beta-lactam allergies, surgical site infections, and prophylaxis in solid organ transplant recipients at a single center: a retrospective cohort study.","volume":"24","author":"Mowrer","year":"2022","journal-title":"Transpl Infect Dis"},{"key":"R16-20250604","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/lt.23682","article-title":"Surgical site infections in liver transplant recipients in the model for end-stage liver disease era: an analysis of the epidemiology, risk factors, and outcomes.","volume":"19","author":"Freire","year":"2013","journal-title":"Liver Transpl"},{"key":"R17-20250604","doi-asserted-by":"crossref","first-page":"e13941","DOI":"10.1111\/tid.13941","article-title":"Epidemiology and outcomes of surgical site infections among pediatric liver transplant recipients.","volume":"24","author":"Banach","year":"2022","journal-title":"Transpl Infect Dis"},{"key":"R18-20250604","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1097\/TP.0b013e3181a25133","article-title":"Surgical site infection after liver transplantation: risk factors and association with graft loss or death.","volume":"87","author":"Hellinger","year":"2009","journal-title":"Transplantation"},{"key":"R19-20250604","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1067\/msy.2001.116666","article-title":"The effect of surgical site infections on outcomes and resource utilization after liver transplantation.","volume":"130","author":"Hollenbeak","year":"2001","journal-title":"Surgery"},{"key":"R20-20250604","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/TP.0000000000001848","article-title":"Perioperative antibiotic prophylaxis to prevent surgical site infections in solid organ transplantation.","volume":"102","author":"Anesi","year":"2018","journal-title":"Transplantation"},{"key":"R21-20250604","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1016\/j.ajic.2016.12.010","article-title":"Surveillance culture for multidrug-resistant gram-negative bacteria: performance in liver transplant recipients.","volume":"45","author":"Freire","year":"2017","journal-title":"Am J Infect Control"},{"key":"R22-20250604","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1089\/sur.2010.021","article-title":"Surgical site infection prevention: how we do it.","volume":"11","author":"Hranjec","year":"2010","journal-title":"Surg Infect (Larchmt)"},{"key":"R23-20250604","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/lt.25486","article-title":"Intraoperative versus extended antibiotic prophylaxis in liver transplant surgery: a randomized controlled pilot trial.","volume":"25","author":"Berry","year":"2019","journal-title":"Liver Transpl"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004810","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T18:07:44Z","timestamp":1749060464000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,4]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000004810","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,4]]}}}